Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3 | 12 | 12 | 56 | 57 |
| Receivables | 107 | 106 | 104 | 102 | 101 |
| TOTAL | $111 | $117 | $116 | $158 | $161 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $111 | $117 | $116 | $158 | $161 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 38 | 28 | 11 | 29 | 15 |
| Accrued Expenses | 14 | 7 | 8 | 0 | 0 |
| TOTAL | $52 | $34 | $19 | $29 | $15 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $52 | $34 | $19 | $29 | $15 |
| Shareholders' Equity | |||||
| Common Shares | 316 | 316 | 316 | 316 | 316 |
| Retained earnings | -347 | -322 | -308 | -277 | -259 |
| Other shareholders' equity | 90 | 90 | 90 | 90 | 90 |
| TOTAL | $58 | $83 | $97 | $129 | $146 |
| Total Liabilities And Equity | $111 | $117 | $116 | $158 | $161 |